首页> 美国卫生研究院文献>ACS AuthorChoice >NIR-Light-Driven Generation of Reactive Oxygen SpeciesUsing Ru(II)-Decorated Lipid-Encapsulated Upconverting Nanoparticles
【2h】

NIR-Light-Driven Generation of Reactive Oxygen SpeciesUsing Ru(II)-Decorated Lipid-Encapsulated Upconverting Nanoparticles

机译:近红外光驱动产生的活性氧使用Ru(II)装饰脂质包裹的上转换纳米粒子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The biological application of ruthenium anticancer prodrugs for photodynamic therapy (PDT) and photoactivated chemotherapy (PACT) is restricted by the need to use poorly penetrating high-energy photons for their activation, i.e., typically blue or green light. Upconverting nanoparticles (UCNPs), which produce high-energy light under near-infrared (NIR) excitation, may solve this issue, provided that the coupling between the UCNP surface and the Ru prodrug is optimized to produce stable nanoconjugates with efficient energy transfer from the UCNP to the ruthenium complex. Herein, we report on the synthesis and photochemistry of the two structurally related ruthenium(II) polypyridyl complexes [Ru(bpy)2(>5)](PF6)2 ([>1](PF6)2) and [Ru(bpy)2(>6)](PF6)2 ([>2](PF6)2), where bpy = 2,2-bipyridine, >5 is 5,6-bis(dodecyloxy)-2,9-dimethyl-1,10-phenanthroline, and >6 is 5,6-bis(dodecyloxy)-1,10-phenanthroline. [>1](PF6)2 is photolabile as a result of the steric strain induced by ligand >5, but the irradiation of [>1](PF6)2 in solution leads to the nonselective and slow photosubstitution of one of its three ligands, making it a poor PACT compound. On the other hand, [>2](PF6)2 is an efficient and photostablePDT photosensitizer. The water-dispersible, negatively charged nanoconjugateUCNP@lipid/[>2] was prepared by the encapsulation of 44nm diameter NaYF4:Yb3+,Tm3+ UCNPsin a mixture of 1,2-dioleoyl-sn-glycero-3-phosphateand 1,2-dioleoyl-sn-glycero-3-phosphocholine phospholipids,cholesterol, and the amphiphilic complex [>2](PF6)2. A nonradiative energy transfer efficiency of 12% betweenthe Tm3+ ions in the UCNP and the Ru2+ acceptor[>2]2+ was found using time-resolved emissionspectroscopy. Under irradiation with NIR light (969 nm), UCNP@lipid/[>2] was found to produce reactive oxygen species (ROS), asjudged by the oxidation of the nonspecific ROS probe 2′,7′-dichlorodihydrofluorescein(DCFH2–). Determination of the type of ROS producedwas precluded by the negative surface charge of the nanoconjugate,which resulted in the electrostatic repulsion of the more specificbut also negatively charged 1O2 probe tetrasodium9,10-anthracenediyl-bis(methylene)dimalonate (Na4(ADMBMA)).
机译:钌抗癌前药在光动力疗法(PDT)和光活化化学疗法(PACT)中的生物学应用受到需要使用渗透性差的高能光子活化的限制,即通常是蓝光或绿光。上转换纳米粒子(UCNPs)在近红外(NIR)激发下产生高能光,可以解决此问题,前提是UCNP表面和Ru前药之间的偶联经过优化以产生稳定的纳米共轭物,并能有效地从纳米粒子中转移能量。 UCNP与钌配合物。在此,我们报道了两种与结构相关的钌(II)聚吡啶基配合物[Ru(bpy)2(> 5 )](PF6)2([> 1 ](PF6)2)和[Ru(bpy)2(> 6 )](PF6)2([> 2 ](PF6)2),其中bpy = 2 ,2-联吡啶,> 5 是5,6-双(十二烷氧基)-2,9-二甲基-1,10-菲咯啉,> 6 是5,6-双(十二烷氧基)-1,10-菲咯啉。 [> 1 ](PF6)2由于配体> 5 引起的空间应变而对光不稳定,但[> 1 ](溶液中的PF6)2导致其三个配体之一的非选择性和缓慢光解,使其成为不良的PACT化合物。另一方面,[> 2 ](PF6)2是高效且稳定的PDT光敏剂。水分散性,带负电荷的纳米共轭物UCNP @ lipid / [> 2 ]是通过封装44纳米直径NaYF 4 :Yb 3 + ,Tm 3 + UCNPs在1,2-二油酰基-sn-甘油-3-磷酸的混合物中和1,2-二油酰基-sn-甘油-3-磷酸胆碱磷脂,胆固醇和两亲性复合物[> 2 ](PF 6 2 。之间的非辐射能量转移效率为12%UCNP中的Tm 3 + 离子和Ru 2 + 受体使用时间分辨发射发现了[> 2 ] 2 + 光谱学。在近红外光(969 nm)照射下,发现UCNP @ lipid / [> 2 ]会产生活性氧(ROS),因为非特异性ROS探针2',7'-二氯二氢荧光素的氧化反应判断(DCFH 2 – )。确定产生的ROS的类型被纳米复合物的负表面电荷所阻止,导致更排斥的静电排斥而且带负电的 1 O 2 探针四钠9,10-蒽二甲双(亚甲基)二羟甲基磺酸钠(Na 4 (ADMBMA))。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号